Long-term prognosis of parathyroid function after successful percutaneous ethanol injection therapy (PEIT) guided by color Doppler flow mapping in chronic dialysis patients

Biomedicine and Pharmacotherapy

Volumn 54, Issue SUPPL. 1, 2000, Pages 60s-65s

  Kakuta, Takatoshi ^a   Kunimatsu, K ^a   Tadaki, F ^a   Fujisaki, T ^a   Noguchi, M ^a   Abe, Y ^a   Sakai, H ^a   Kurokawa, K ^a   Saito, A ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Dialysis; Ethanol injection; Parathyroid hormone; Parathyroid hyperplasia; Renal failure; Uremia

Indexed keywords

ALCOHOL; ALKALINE PHOSPHATASE; CALCITRIOL; PARATHYROID HORMONE;

ADULT; AGED; ARTICLE; COLOR ULTRASOUND FLOWMETRY; FEMALE; HEMODIALYSIS PATIENT; HUMAN; INJECTION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OSTEITIS; PARATHYROID FUNCTION; PARATHYROID HORMONE RELEASE; PARATHYROID HYPERPLASIA; PARATHYROIDECTOMY; PRIORITY JOURNAL; PROGNOSIS; RENAL OSTEODYSTROPHY; SECONDARY HYPERPARATHYROIDISM;

EID: 0033932778     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0753-3322(00)80013-X     Document Type: Article

References (21)

1. Slatopolsky EA, Weerts C, Thielan J, Horst R, Harter H, Martin KJ. Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxycholecaiciferol in uremic patients. J Clin Invest 1984 ; 74 : 2136-43.
2. Fukuda N, Tanaka H, Tominaga Y, Fukagawa M, Kurokawa K, Seino Y. Decreased 1,25-dihydroxyvitamin D3 receptor density associated with a more severe from of parathyroid hyperplasia in chronic uremic patients. J Clin Invest 1993 ; 92 : 1436-43.
3. Sherrard DJ, Hercz G, Pei Y, Maloney NA, Greenwood C, Manuel A, et al. The spectrum of bone diseases in end-stage renal failure- an evolving disorder. Kidney Int 1993 ; 43 : 436-42.
4. Hercz G, Pei Y, Greenwood C, Manuel A, Saiphoo C, Goodman WG, et al. Aplastic osteodystrophy without aluminum: the role of 'suppressed' parathyroid function. Kidney Int 1993 ; 44 : 860-6.
5. De Broe ME, Drucke TB, Ritz E. Consensus conference on the diagnosis and treatment of aluminum overload in end-stage renal failure patients. Nephrol Dial Transplant 1993 ; 8 : 1-4.
6. Drucke TB. The pathogenesis of parathyroid gland hyperplasia in chronic renal failure. Kidney Int 1995 ; 48 : 259-72.
7. Tominaga Y, Numano M, Tanaka Y, Uchida K, Takagi H. Surgical treatment of renal hyperparathyroidism. Semin Surg Oncol 1997 ; 13 : 87-96.
8. Solbiati L, Giangrande A, Pra LD, Belloti E, Cantu P, Ravetto C. Percutaneous ethanol injection of parathyroid tumor under US guidance: treatment for secondary hyperparathyroidism. Radiology 1985 ; 155 : 607-10.
9. Giangrande A, Castiglioni A, Sorbiati L, Allaria P. Ultrasound guided percutaneous fine needle ethanol injection into parathyroid glands in secondary hyperparathyroidism. Nephrol Dial Transplant 1992 ; 7 : 412-21.
10. Cintin C, Karstrup S, Ladefoged S, Joffe P. Tertiary hyperparathyroidism treated by ultrasonically guided percutaneous fine-needle ethanol injection. Nephron 1994 ; 68 : 217-20.
11. Fukagawa M, Kitaoka M, Kurokawa K. Ultrasonographic intervention of parathyroid hyperplasia in chronic dialysis patients: a theoretical approach. Nephrol Dial Trans 1996 ; 11 : 125-9.
12. Kitaoka M, Fukagawa M, Ogata E, Kurokawa K. Reduction of functioning parathyroid mass by ethanol injection in chronic dialysis patients. Kidney Int 1994 ; 46 : 1110-7.
13. Fukagawa M, Kitaoka M, Inazawa T, Kurokawa K. Imaging of the parathyroid in chronic renal failure: diagnostic and therapeutic aspects. Current Opin Nephrol Hypertens 1997 ; 6 : 349-55.
14. Fukagawa M, Kitaoka M, Kurokawa K. Resistance to vitamin D in chronic renal failure. Kidney Int 1997 ; 52 Suppl 62 : S60-4.
15. Tominaga Y, Kohara S, Namii Y, Nagasaka T, Haba T, Uchida K, et al. Clonal analysis of nodular hyperplasia in renal hyperparathyroidism. World J Surg 1996 ; 20 : 744-52.
16. 2+-sensing receptor in primary and uremic secondary hyperparathyroidism. J Clin Endocrinol Metab 1996 ; 81 : 1598-606.
17. Fukagawa M, Kitaoka M, Yi H, Fukuda N, Matsumoto T, Ogata E, et al. Serial evaluation of parathyroid size by ultrasonography is another useful marker for the long-term prognosis of calcitriol pulse therapy in chronic dialysis patient. Nephron 1994 ; 68 : 221-8.
18. Tominaga Y, Tanaka Y, Sato K, Nagasaka T, Takagi H. Histology, pathophysiology, and indications for surgical treatment of renal hyperparathyroidism. Semin Surg Oncol 1997 ; 13 : 78-86.
19. Bennedbaek FN, Karstrup S, Hegedus L. Percutaneous ethanol injection therapy in the treatment of thyroid and parathyroid diseases. Eur J Endocrinol 1997 ; 136 : 240-50.
20. Akizawa T, Kinugasa E, Akiba T, Tsukamoto Y, Kurokawa K. Incidence and clinical characteristics of hypoparathyroidism in dialysis patients. Kidney Int 1997 ; 52 Suppl 62 : S72-4.
21. Rudnicki M. Residual parathyroid function in chronic surgical hypoparathyroidism. Miner Electrolyte Metab 1991 ; 17 : 331-4.